Enhanced snoMEN Vectors Facilitate Institution of GFP-HIF-1α Protein Substitute Human Cell Traces.
The snoMEN (snoRNA Modulator of gene ExpressioN) vector expertise was developed from a human field C/D snoRNA, HBII-180C, which accommodates an inside sequence that may be manipulated to make it complementary to RNA targets, permitting knock-down of focused genes. Right here we’ve got screened further human nucleolar snoRNAs and assessed their software for gene particular knock-downs to enhance the effectivity of snoMEN vectors.
We establish and characterise a brand new snoMEN vector, termed 47snoMEN, that’s derived from field C/D snoRNA U47, demonstrating its use for knock-down of each endogenous mobile proteins and G/YFP-fusion proteins.
Utilizing multiplex 47snoMEM vectors that co-express a number of 47snoMEN in a single transcript, every of which may goal totally different websites in the identical mRNA, we doc >3-fold improve in knock-down effectivity when put next with the unique HBII-180C primarily based snoMEN.
The multiplex 47snoMEM vector allowed the development of human protein alternative cell traces with improved effectivity, together with the institution of novel GFP-HIF-1α alternative cells.
Quantitative mass spectrometry evaluation confirmed the improved effectivity and specificity of protein alternative utilizing the 47snoMEN-PR vectors. The 47snoMEN vectors develop the potential purposes for snoMEN expertise in gene expression research, goal validation and gene remedy
gfpvector
 NACC1 Antibody |
|||
| CSB-PA283286- | Cusabio | EUR 335 | |
|
|||
|
Description: A polyclonal antibody against NACC1. Recognizes NACC1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:1000 |
|||
NACC1 Antibody |
|||
| CSB-PA283286-100ul | Cusabio | 100ul | EUR 316 |
|
|||
|
Description: A polyclonal antibody against NACC1. Recognizes NACC1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:1000 |
|||
NACC1 Antibody |
|||
| BF0187 | Affbiotech | 200ul | EUR 376 |
|
Description: NACC1 antibody detects endogenous levels of total NACC1. |
|||
 NACC1 siRNA |
|||
| 20-abx903454 | Abbexa |
|
|
|
|||
NACC1 siRNA |
|||
| 20-abx925337 | Abbexa |
|
|
|
|||
NACC1 siRNA |
|||
| 20-abx925338 | Abbexa |
|
|
|
|||
 Human NACC1 shRNA Plasmid |
|||
| 20-abx964300 | Abbexa |
|
|
|
|||
) NACC1 Recombinant Protein (Human) |
|||
| RP077613 | ABM | 100 ug | Ask for price |
 (CMV) (pLenti-GIII-CMV)) NACC1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV) |
|||
| LV693127 | ABM | 1.0 ug DNA | EUR 682 |
 (UbC) (pLenti-GIII-UbC)) NACC1 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV693131 | ABM | 1.0 ug DNA | EUR 682 |
 (EF1a) (pLenti-GIII-EF1a)) NACC1 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV693132 | ABM | 1.0 ug DNA | EUR 682 |
 (pORF)) Nacc1 ORF Vector (Rat) (pORF) |
|||
| ORF071065 | ABM | 1.0 ug DNA | EUR 506 |
 (pORF)) Nacc1 ORF Vector (Mouse) (pORF) |
|||
| ORF050990 | ABM | 1.0 ug DNA | EUR 506 |
 NACC1 Rabbit pAb |
|||
| A11709-100ul | Abclonal | 100 ul | EUR 308 |
NACC1 Rabbit pAb |
|||
| A11709-200ul | Abclonal | 200 ul | EUR 459 |
NACC1 Rabbit pAb |
|||
| A11709-20ul | Abclonal | 20 ul | EUR 183 |
NACC1 Rabbit pAb |
|||
| A11709-50ul | Abclonal | 50 ul | EUR 223 |
NACC1 Rabbit pAb |
|||
| A11720-100ul | Abclonal | 100 ul | EUR 308 |
NACC1 Rabbit pAb |
|||
| A11720-200ul | Abclonal | 200 ul | EUR 459 |
NACC1 Rabbit pAb |
|||
| A11720-20ul | Abclonal | 20 ul | EUR 183 |
NACC1 Rabbit pAb |
|||
| A11720-50ul | Abclonal | 50 ul | EUR 223 |
 NACC1 Conjugated Antibody |
|||
| C48470 | SAB | 100ul | EUR 397 |
 NACC1 Blocking Peptide |
|||
| BF0187-BP | Affbiotech | 1mg | EUR 195 |
) anti-NACC1 (6H2) |
|||
| LF-MA30500 | Abfrontier | 100 ul | EUR 486 |
|
Description: Mouse Monoclonal to NACC1 |
|||
 Anti-NACC1 antibody |
|||
| STJ113308 | St John's Laboratory | 100 µl | EUR 277 |
|
Description: This gene encodes a member of the BTB/POZ protein family. BTB/POZ proteins are involved in several cellular processes including proliferation, apoptosis and transcription regulation. The encoded protein is a transcriptional repressor that plays a role in stem cell self-renewal and pluripotency maintenance. The encoded protein also suppresses transcription of the candidate tumor suppressor Gadd45GIP1, and expression of this gene may play a role in the progression of multiple types of cancer. A pseudogene of this gene is located on the short arm of chromosome 9. |
|||
Anti-NACC1 antibody |
|||
| STJ113847 | St John's Laboratory | 100 µl | EUR 277 |
|
Description: This gene encodes a member of the BTB/POZ protein family. BTB/POZ proteins are involved in several cellular processes including proliferation, apoptosis and transcription regulation. The encoded protein is a transcriptional repressor that plays a role in stem cell self-renewal and pluripotency maintenance. The encoded protein also suppresses transcription of the candidate tumor suppressor Gadd45GIP1, and expression of this gene may play a role in the progression of multiple types of cancer. A pseudogene of this gene is located on the short arm of chromosome 9. |
|||
 (pPB-C-His)) NACC1 Protein Vector (Human) (pPB-C-His) |
|||
| PV103486 | ABM | 500 ng | EUR 552 |
 (pPB-N-His)) NACC1 Protein Vector (Human) (pPB-N-His) |
|||
| PV103487 | ABM | 500 ng | EUR 552 |
 (pPM-C-HA)) NACC1 Protein Vector (Human) (pPM-C-HA) |
|||
| PV103488 | ABM | 500 ng | EUR 552 |
 (pPM-C-His)) NACC1 Protein Vector (Human) (pPM-C-His) |
|||
| PV103489 | ABM | 500 ng | EUR 552 |
) Polyclonal NACC1 Antibody (Center) |
|||
| APR04758G | Leading Biology | 0.1ml | EUR 484 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NACC1 (Center). This antibody is tested and proven to work in the following applications: |
|||
 Rat NACC1 shRNA Plasmid |
|||
| 20-abx987779 | Abbexa |
|
|
|
|||
 Mouse NACC1 shRNA Plasmid |
|||
| 20-abx975804 | Abbexa |
|
|
|
|||
) NACC1 Recombinant Protein (Mouse) |
|||
| RP152966 | ABM | 100 ug | Ask for price |
) NACC1 Recombinant Protein (Rat) |
|||
| RP213191 | ABM | 100 ug | Ask for price |
) NACC1 sgRNA CRISPR Lentivector set (Human) |
|||
| K1386401 | ABM | 3 x 1.0 ug | EUR 339 |
 (pPB-C-His)) NACC1 Protein Vector (Mouse) (pPB-C-His) |
|||
| PV203958 | ABM | 500 ng | EUR 603 |
 (pPB-N-His)) NACC1 Protein Vector (Mouse) (pPB-N-His) |
|||
| PV203959 | ABM | 500 ng | EUR 603 |
 (pPM-C-HA)) NACC1 Protein Vector (Mouse) (pPM-C-HA) |
|||
| PV203960 | ABM | 500 ng | EUR 603 |
 (pPM-C-His)) NACC1 Protein Vector (Mouse) (pPM-C-His) |
|||
| PV203961 | ABM | 500 ng | EUR 603 |
 (pPB-C-His)) NACC1 Protein Vector (Rat) (pPB-C-His) |
|||
| PV284258 | ABM | 500 ng | EUR 603 |
 (pPB-N-His)) NACC1 Protein Vector (Rat) (pPB-N-His) |
|||
| PV284259 | ABM | 500 ng | EUR 603 |
 (pPM-C-HA)) NACC1 Protein Vector (Rat) (pPM-C-HA) |
|||
| PV284260 | ABM | 500 ng | EUR 603 |
 (pPM-C-His)) NACC1 Protein Vector (Rat) (pPM-C-His) |
|||
| PV284261 | ABM | 500 ng | EUR 603 |
 (CMV) (pLenti-GIII-CMV-C-term-HA)) NACC1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-C-term-HA) |
|||
| LV693128 | ABM | 1.0 ug DNA | EUR 682 |
 (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)) NACC1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro) |
|||
| LV693129 | ABM | 1.0 ug DNA | EUR 740 |
 (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)) NACC1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro) |
|||
| LV693130 | ABM | 1.0 ug DNA | EUR 740 |
) Polyclonal NACC1 Antibody (C-term) |
|||
| APR04778G | Leading Biology | 0.1ml | EUR 484 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NACC1 (C-term). This antibody is tested and proven to work in the following applications: |
|||
 (Target 1)) NACC1 sgRNA CRISPR Lentivector (Human) (Target 1) |
|||
| K1386402 | ABM | 1.0 ug DNA | EUR 154 |
 (Target 2)) NACC1 sgRNA CRISPR Lentivector (Human) (Target 2) |
|||
| K1386403 | ABM | 1.0 ug DNA | EUR 154 |
 (Target 3)) NACC1 sgRNA CRISPR Lentivector (Human) (Target 3) |
|||
| K1386404 | ABM | 1.0 ug DNA | EUR 154 |
 Antibody) Nucleus Accumbens Associated 1 (NACC1) Antibody |
|||
| 20-abx126214 | Abbexa |
|
|
|
|||
Nucleus Accumbens Associated 1 (NACC1) Antibody |
|||
| abx011231-100ul | Abbexa | 100 ul | EUR 411 |
|
|||
Nucleus Accumbens Associated 1 (NACC1) Antibody |
|||
| abx330473-100ul | Abbexa | 100 ul | EUR 425 |
|
|||
) Nacc1 sgRNA CRISPR Lentivector set (Mouse) |
|||
| K4905601 | ABM | 3 x 1.0 ug | EUR 339 |
) Nacc1 sgRNA CRISPR Lentivector set (Rat) |
|||
| K7051401 | ABM | 3 x 1.0 ug | EUR 339 |
 Human Nucleus accumbens- associated protein 1, NACC1 ELISA KIT |
|||
| ELI-16141h | Lifescience Market | 96 Tests | EUR 824 |
 (Target 1)) Nacc1 sgRNA CRISPR Lentivector (Mouse) (Target 1) |
|||
| K4905602 | ABM | 1.0 ug DNA | EUR 154 |
 (Target 2)) Nacc1 sgRNA CRISPR Lentivector (Mouse) (Target 2) |
|||
| K4905603 | ABM | 1.0 ug DNA | EUR 154 |
 (Target 3)) Nacc1 sgRNA CRISPR Lentivector (Mouse) (Target 3) |
|||
| K4905604 | ABM | 1.0 ug DNA | EUR 154 |
 (Target 1)) Nacc1 sgRNA CRISPR Lentivector (Rat) (Target 1) |
|||
| K7051402 | ABM | 1.0 ug DNA | EUR 154 |
 (Target 2)) Nacc1 sgRNA CRISPR Lentivector (Rat) (Target 2) |
|||
| K7051403 | ABM | 1.0 ug DNA | EUR 154 |
 (Target 3)) Nacc1 sgRNA CRISPR Lentivector (Rat) (Target 3) |
|||
| K7051404 | ABM | 1.0 ug DNA | EUR 154 |
 Nacc1 3'UTR Luciferase Stable Cell Line |
|||
| TU113804 | ABM | 1.0 ml | Ask for price |
 Nacc1 3'UTR GFP Stable Cell Line |
|||
| TU163804 | ABM | 1.0 ml | Ask for price |
Nacc1 3'UTR Luciferase Stable Cell Line |
|||
| TU213713 | ABM | 1.0 ml | Ask for price |
Nacc1 3'UTR GFP Stable Cell Line |
|||
| TU263713 | ABM | 1.0 ml | Ask for price |
 NACC1 3'UTR GFP Stable Cell Line |
|||
| TU065180 | ABM | 1.0 ml | EUR 1521 |
 NACC1 3'UTR Luciferase Stable Cell Line |
|||
| TU015180 | ABM | 1.0 ml | EUR 1521 |
) NACC1 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human) |
|||
| K1386405 | ABM | 3 x 1.0 ug | EUR 376 |
 (Target 1)) NACC1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1) |
|||
| K1386406 | ABM | 1.0 ug DNA | EUR 167 |
 (Target 2)) NACC1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2) |
|||
| K1386407 | ABM | 1.0 ug DNA | EUR 167 |
 (Target 3)) NACC1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3) |
|||
| K1386408 | ABM | 1.0 ug DNA | EUR 167 |
 Mouse Nucleus accumbens- associated protein 1, Nacc1 ELISA KIT |
|||
| ELI-38383m | Lifescience Market | 96 Tests | EUR 865 |
) Nacc1 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse) |
|||
| K4905605 | ABM | 3 x 1.0 ug | EUR 376 |
) Nacc1 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat) |
|||
| K7051405 | ABM | 3 x 1.0 ug | EUR 376 |
 (Target 1)) Nacc1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1) |
|||
| K4905606 | ABM | 1.0 ug DNA | EUR 167 |
 (Target 2)) Nacc1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2) |
|||
| K4905607 | ABM | 1.0 ug DNA | EUR 167 |
 (Target 3)) Nacc1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3) |
|||
| K4905608 | ABM | 1.0 ug DNA | EUR 167 |
 (Target 1)) Nacc1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1) |
|||
| K7051406 | ABM | 1.0 ug DNA | EUR 167 |
A replicating plasmid-based vector for GFP expression in Mycoplasma hyopneumoniae.
Mycoplasma hyopneumoniae (M. hyopneumoniae) causes porcine enzootic pneumonia (PEP) that considerably impacts the pig trade worldwide. Regardless of the provision of the entire genome sequence, research on the pathogenesis of this organism have been restricted as a result of lack of a genetic manipulation system.
Subsequently, the intention of the present examine was to generate a common GFP reporter vector primarily based on a replicating plasmid. Right here, we describe the feasibility of GFP reporter expression in M. hyopneumoniae (pressure 168L) managed by the p97 gene promoter of this mycoplasma. An expression plasmid (pMD18-TOgfp) containing the p97 gene promoter, and origin of replication (oriC) of M. hyopneumoniae, tetracycline resistant marker (tetM), and GFP was constructed and used to rework competent M. hyopneumoniae cells.
We noticed inexperienced fluorescence in M. hyopneumoniae transformants beneath fluorescence microscopy, which signifies that there was expression of the GFP reporter that was pushed by the p97 gene promoter.
Moreover, an electroporation methodology for M. hyopneumoniae with an effectivity of roughly 1 x 10(-6) transformants/μg plasmid DNA was optimized and is described herein. In conclusion, our information display the susceptibility of M. hyopneumoniae to genetic manipulation whereby overseas genes are expressed. This work might encourage the event of genetic instruments to govern the genome of M. hyopneumoniae for practical genomic analyses.
Human adipose derived mesenchymal stromal cells transduced with GFP lentiviral vectors: evaluation of immunophenotype and differentiation capability in vitro.
Adipose derived mesenchymal stromal/stem cells (ASCs) are a heterogeneous inhabitants characterised by (a) their potential to stick to plastic; (b) immunophenotypic expression of sure cell floor markers, whereas missing others; and (c) the capability to distinguish into lineages of mesodermal origin together with osteocytes, chondrocytes and adipocytes. The long-term objective is to make the most of these cells for medical translation into cell-based therapies. Nonetheless, preclinical security and efficacy have to be demonstrated in animal fashions.
ASCs will also be utilized as organic autos for vector-based gene supply techniques, since they’re believed to dwelling to websites of irritation and an infection in vivo. These elements motivated the event of a labelling system for ASCs utilizing lentiviral vector-based inexperienced fluorescent protein (GFP) transduction. Human ASCs had been transduced with GFP-expressing lentiviral vectors. A titration examine decided the viral titer required to transduce the utmost variety of ASCs.
The impact of the transduced GFP lentiviral vector on ASC immunophenotypic expression of floor markers in addition to their potential to distinguish into osteocytes and adipocytes had been assessed in vitro.
Transduction effectivity in ASC cultures of roughly 80 % was noticed with an MOI of ~118. No important immunophenotypic variations had been noticed between transduced and non-transduced cells and each cell sorts efficiently differentiated into adipocytes and osteocytes in vitro. We obtained >80 % transduction of ASCs utilizing GFP lentiviral vectors.
Transduced ASCs maintained plastic adherence, demonstrated ASC immunophenotype and the flexibility to distinguish into cells of the mesodermal lineage. This GFP-ASC transduction approach provides a possible monitoring system for future pre-clinical research.
Product not found